I never thought you were implying buy out. It’s just a matter of time before we get that type of offer. I agree with that. It’s something I dread to see because there will be many that will want to take that offer and not have the patience to see the immediate future and how quickly things will change with our first full approval. We will be able to bring other indications to approvals very quickly after we get our first approval.

It will be a decision we will all make and vote on but the serious money is in becoming our own pharmaceutical company. We are talking the difference between $100 to $1,000 a share price some day. In my opinion. It won’t take long to build that price up. I looked at Humira and Truvada and as a platform drug they were getting approved indications at as many as 7 different indication each year. Could you imagine with 65+ indications that science proves we may have a positive effect on these indications that we too could become the biggest platform drug. Truvada has 36 or 37 indication approvals I believe right now. Give us 7 indications a year and with our blockbuster indications… we are hitting it big and still growing annuall for years and years.

Please Craig keep you opinion to yourself. We know your pessimistic view might not allow you to not comment. But when we know what you stand for why show us when we don’t really care about your view.